*Daisy Spark^1,2, Juulke Castelijn^1,2, Leonid Churilov³, Trang Pham^2,4, Michelle Camerino^2,4, Christopher J Langmead^2,5,6, Gregory D Stewart^2,5,6, Jess Nithianantharajah^1,2 (1. The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia, 2. Phrenix Therapeutics, Parkville, Victoria, Australia, 3. Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia, 4. Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 5. Drug Discovery Biology, Neuroscience & Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, 6. Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia)

*Courtney Leigh Clarke¹, Skylar Donovan¹, SM Nageeb Hasan¹, Francis Bambico¹ (1. Memorial University of Newfoundland and Labrador)

*Rinako Tanaka¹, Yue Liu¹, Jingzhu Liao¹, Akihiro Mouri², Taku Nagai³, Toshitaka Nabeshima⁴, Kozo Kaibuchi⁵, Daiki Tachibana⁶, Yohei Kobayashi⁶, Norio Ozaki⁷, Hiroyuki Mizoguchi¹, Kiyofumi Yamada^1,8 (1. Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Science, Toyoake, Japan, 3. Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Japan, 4. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan, 5. Division of Cell Biology, ICBS, Fujita Health University, Toyoake, Japan, 6. Pharmacology Research Unit, Sumitomo Pharma Co., Ltd., Osaka, Japan, 7. Pathophysiology of mental disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan, 8. ICBS, Fujita Health University, Toyoake, Japan)

*Martha Lopez Canul¹, Vivienne Nguyen¹, Antonio Inserra¹, Ella Nield¹, Hannah Billings¹, Gabriella Gobbi¹ (1. McGill University, Department of Psychiatry and Alan Edwards Centre for Research on Pain, Montréal, QC, Canada)

*Chihiro Nozaki¹, Haruka Hosoki², Andreas Zimmer³ (1. Global Center for Science and Engineering, Waseda University, Tokyo, Japan, 2. Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan, 3. Institute of Molecular Psychiatry, University of Bonn, Bonn, Germany)